nn

Women’s Hormone Care • Board-Certified Internal Medicine

Menopause & Perimenopause Treatment in Los Angeles

Fit woman in her 40s or 50s running outdoors, representing menopause and perimenopause wellness

Comprehensive evaluation and individualized care for women experiencing symptoms during the menopause transition. David Nazarian, M.D., Board Certified in Internal Medicine, evaluates the whole patient—not only hormone levels—to determine whether menopausal hormone therapy, nonhormonal treatment, local therapy, lifestyle measures, nutrition or supplementation, or another medical approach may be appropriate. His multidisciplinary approach also considers bone health, cardiovascular and metabolic risk, sleep, cognitive concerns, sexual and genitourinary symptoms, medications and other conditions that can overlap with menopause.

Understanding Perimenopause and Menopause

Perimenopause

Perimenopause is the transition leading up to menopause. Hormone levels and menstrual patterns may fluctuate, and symptoms can begin even when periods are still occurring. The duration and experience vary considerably from one woman to another.

Menopause

Natural menopause is identified after 12 consecutive months without a menstrual period when another cause is not responsible. Menopause can also occur after surgery or certain medical treatments.

Symptoms, health risks, and treatment priorities may differ during perimenopause, at the time of menopause, and in the years afterward. A personalized assessment helps distinguish the stage of transition and evaluate other possible explanations.

Symptoms That May Bring Women to the Office

Temperature & Sleep

Hot flashes, night sweats, disrupted sleep, and fatigue.

Mood & Cognition

Mood changes, irritability, anxiety, difficulty concentrating, or perceived brain fog.

Sexual & Vaginal Health

Vaginal dryness, discomfort with intercourse, urinary symptoms, or changes in sexual interest.

Physical Changes

Changes in menstrual patterns, body composition, joint symptoms, skin or hair, and bone-health concerns.

These symptoms are not specific to menopause. Thyroid disorders, anemia, sleep disorders, medication effects, mood conditions, metabolic problems, nutritional deficiencies, and other medical concerns can produce overlapping symptoms.

A Comprehensive Menopause Evaluation

Clinical History

Symptoms, menstrual history, pregnancy and gynecologic history, prior treatments, medications, sleep, lifestyle, family history, and personal goals.

Health & Risk Review

Cardiovascular risk, blood pressure, breast and gynecologic history, blood-clot history, liver health, bone health, cancer risk, and age-appropriate screening.

Selective Testing

Testing is chosen according to the clinical question. Not every woman needs the same hormone panel, and normal fluctuation can limit the usefulness of a single measurement.

Woman learning about perimenopause symptoms and treatment options

Treatment Options Are Chosen Individually

Treatment depends on the symptom being addressed, the stage of menopause, whether the uterus is present, medical history, personal risk factors, preferences, and the expected balance of benefits and risks.

Systemic Hormone Therapy

Systemic estrogen may be considered for appropriate patients with bothersome vasomotor symptoms. A progestogen is generally needed to protect the endometrium when systemic estrogen is used in a woman with a uterus.

Local Vaginal Therapy

Low-dose vaginal treatment may be considered for genitourinary symptoms such as vaginal dryness, discomfort, or selected urinary concerns. Its indications and risk considerations differ from systemic therapy.

Nonhormonal Options

Prescription nonhormonal medications, vaginal moisturizers and lubricants, sleep treatment, behavioral approaches, and management of contributing medical conditions may be appropriate.

Nonhormonal Symptom Management

Older versions of this page included useful detail on antidepressant-class medications used for vasomotor symptoms, gabapentin, clonidine, cooling strategies, regular exercise, sleep habits, plant-based products and acupuncture. These options do not all have the same level of evidence, and treatment should be matched to the symptom, medical history and patient preference. This material is now being organized into focused hot-flash and menopause-support resources rather than repeated across the menopause pillar.

Lifestyle & Preventive Care

Exercise, nutrition, resistance training, sleep, tobacco avoidance, alcohol moderation, bone-health strategies, and recommended screening remain important whether or not hormone therapy is used.

Potential Benefits and Limitations

For appropriately selected patients, menopausal hormone therapy can be effective for vasomotor symptoms and may help with certain menopause-related concerns. It is not a universal treatment for every symptom, does not prevent normal aging, and should not be presented as a guaranteed solution for weight, energy, mood, cognition, sexual function, or overall wellness.

The lowest effective dose, appropriate route, treatment goals, and duration should be revisited over time rather than assumed to be permanent.

When Additional Caution Is Needed

A more detailed risk assessment or specialist coordination may be needed with unexplained vaginal bleeding, a history of certain hormone-sensitive cancers, blood clots, stroke, heart attack, significant liver disease, or other complex medical conditions.

This does not replace individualized medical advice. Risk varies by patient and by the type, dose, route, and timing of treatment.

FDA-Approved and Compounded Hormones

Many FDA-approved hormone products use estradiol or micronized progesterone that are chemically identical to hormones produced in the body. Compounded preparations may be considered in selected circumstances, such as a documented need for a dosage form or ingredient combination that is not commercially available.

The word bioidentical does not by itself mean that a therapy is natural, safer, or more effective. Product quality, dosing consistency, evidence, indication, and monitoring matter more than marketing terminology.

Monitoring and Follow-Up

Follow-up may include review of symptom response, side effects, blood pressure, medication adherence, changes in medical history, appropriate screening, and selected laboratory testing. Treatment may be adjusted, changed, or discontinued when benefits are limited or risks change.

Unexpected bleeding, new breast symptoms, chest pain, sudden shortness of breath, neurologic symptoms, or other concerning changes require timely medical assessment.

David Nazarian, M.D.

Board-Certified in Internal Medicine

Dr. Nazarian approaches menopause care within the broader context of cardiovascular, metabolic, sleep, thyroid, medication, and preventive health considerations.

What to Expect

1. Consultation

Discuss symptoms, menstrual history, medical background, prior treatment, concerns, and goals.

2. Evaluation

Review health risks, screening history, medications, and other possible causes of symptoms.

3. Shared Decision

Compare hormone and nonhormonal options, expected benefits, limitations, and risks.

4. Follow-Up

Monitor response and safety, revisit goals, and adjust the plan when clinically appropriate.

Medical Author & Reviewer

Written by: David Nazarian, M.D.
Medically reviewed by: David Nazarian, M.D.
Medical review date: September 17, 2026

David Nazarian, M.D., is Board-Certified in Internal Medicine and has extensive experience evaluating and treating women and men with hormonal concerns. His approach emphasizes comprehensive assessment, evidence-informed decision-making, patient education, individualized treatment, safety, and ongoing follow-up.

Frequently Asked Questions

In many women over age 45 with a typical menstrual history and symptoms, menopause is primarily a clinical diagnosis. Testing may be appropriate when the presentation is atypical, menopause appears early, periods are absent for another possible reason, or another condition is being considered.
Perimenopause is the transition before menopause, when cycles and hormone levels may fluctuate. Menopause is recognized after 12 consecutive months without a menstrual period when another cause is not responsible. Read our detailed perimenopause vs. menopause guide.
No. Treatment depends on symptoms, health history, risk factors, preferences, and whether the expected benefits outweigh potential risks. Some women need no medication; others may benefit from hormonal or nonhormonal treatment.
The term bioidentical does not establish that a product is safer or more effective. FDA-approved bioidentical options exist. Compounded therapy may be appropriate for selected needs, but quality, dosing, evidence, and monitoring should be considered.
Hormone therapy is not a weight-loss treatment. Body composition may change during midlife, but weight is also influenced by sleep, activity, nutrition, medications, metabolic health, and other factors.
There is no single duration that is appropriate for every woman. The indication, symptom burden, age, time since menopause, dose, route, personal risks, and preferences should be reassessed periodically.
Nonhormonal prescription treatments, local nonhormonal products, behavioral strategies, sleep treatment, and management of contributing health conditions may be considered depending on the symptom.
Testosterone is not a general menopause or wellness treatment. Evidence is strongest for carefully selected postmenopausal women with hypoactive sexual desire disorder, and treatment requires appropriate dosing and monitoring.
Genitourinary syndrome of menopause may respond to local vaginal therapies or other targeted treatments that differ from systemic HRT. Read our GSM and vaginal atrophy guide.
Treatment depends on the symptom and the individual patient. Menopausal hormone therapy is among the most effective treatments for bothersome vasomotor symptoms in appropriately selected patients. Local vaginal therapies can be useful for genitourinary symptoms, while evidence-based nonhormonal medications and lifestyle measures may be appropriate for some patients.
Side effects vary by treatment. Hormone therapy can cause effects such as breast tenderness, bleeding or spotting, bloating, headache or skin irritation depending on the formulation, and it also has important risk considerations that depend on the patient and route. Nonhormonal medications have their own side-effect profiles. Treatment should be individualized and reviewed if side effects occur.
Telehealth may be appropriate for portions of menopause evaluation and follow-up when clinically suitable and legally permitted. Depending on symptoms and medical history, an in-person examination, laboratory testing, imaging or other evaluation may still be recommended. Learn about telehealth hormone services in California.
Evidence varies widely among supplements and over-the-counter menopause products, and product quality and interactions also matter. A clinician can review the specific symptom, current medications and health history before a supplement is added, especially when products make hormone-balancing or treatment claims. Read our evidence guide to menopause supplements.

Perimenopause Care

Symptoms often begin before the final menstrual period. Our new Perimenopause Treatment in Los Angeles page explains cycle changes, hot flashes, sleep and mood symptoms, evaluation, and treatment options during the menopause transition.

Areas We Serve

Our Beverly Hills office serves patients from across greater Los Angeles seeking individualized menopause and women’s hormone care.

Commonly served areas include: Beverly Hills, West Hollywood, Century City, Brentwood, Santa Monica, West Los Angeles, Bel Air, Culver City, Hollywood, and Pacific Palisades.

Schedule a Menopause Consultation

Discuss your symptoms, medical history, treatment preferences, and whether hormonal or nonhormonal therapy may be appropriate for you.